Bointy-Tsotigh v. United States

953 F. Supp. 358, 1996 U.S. Dist. LEXIS 21097, 1996 WL 780964
CourtDistrict Court, W.D. Oklahoma
DecidedAugust 27, 1996
DocketCIV-95-1129-L
StatusPublished
Cited by1 cases

This text of 953 F. Supp. 358 (Bointy-Tsotigh v. United States) is published on Counsel Stack Legal Research, covering District Court, W.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bointy-Tsotigh v. United States, 953 F. Supp. 358, 1996 U.S. Dist. LEXIS 21097, 1996 WL 780964 (W.D. Okla. 1996).

Opinion

ORDER

LEONARD, District Judge.

On May 15 and 16, 1996, a bench trial was held in the captioned matter. Upon due consideration and review of the evidence, the court makes its findings of facts and conclusions of law as stated below. Initially, the court accepts the following stipulations submitted by the parties:

Stipulations

1. The Anadarko Indian Health Clinic and the Lawton Indian Hospital (collectively “defendant facilities”) and all persons employed therein are agents of the defendant United States of America.

2. Plaintiff Sandra Bointy-Tsotigh was a patient of defendant facilities during the relevant time frame.

3. Physicians providing treatment to plaintiff were at all times acting within the scope of their employment for defendant.

4. Plaintiff developed colorectal cancer. The cancer was first discovered in June of 1994 by a doctor not affiliated with the Indian Health Service.

5. When plaintiffs cancer was discovered, it had metastasized to four of fourteen regional lymph nodes.

Findings of Fact

1. Plaintiff Sandra Bointy-Tsotigh was bom August 15,1948. Since the death of her husband in June of 1995, plaintiff provides sole support for her 12 and 18 year old daughters and also has another daughter. Plaintiff has a family history of colon cancer.

2. Medical records introduced at trial revealed numerous visits by plaintiff to defendant facilities over the years. Testimony demonstrated four instances in a seventeen month time period in which plaintiff complained of hemorrhoids and/or rectal bleeding to physicians at the defendant facilities. The dates of these visits were: (1) April 6, 1992; (2) April 28, 1992; (3) August 13, 1993; and (4) September 8,1993.

3. Physicians at the defendant facilities did not perform the appropriate diagnostic tests to determine the source of plaintiffs rectal bleeding.

4. Plaintiff testified that she returned for all testing requested by physicians at the defendant facilities. However, there was evidence that plaintiff missed at least one scheduled appointment and gave inconsistent and/or incomplete family and social histories to her health care providers.

5. Expert testimony indicated there were other risk factors present in plaintiffs medical history which should alert a physician to the possibility of colorectal cancer and require the physician to act more aggressively in detecting possible cancer. These include a family history of colorectal cancer, previous gynecological cancer, or other pathologies in the bowel such as a prolapsed rectum or hemorrhoids. Evidence indicates each of these factors was present in plaintiffs medical record, but the physicians at the defendant facilities failed to note them in some instances, and disregarded them in others.

6. The court accepts the testimony of Dr. Lewis Hellerstein that plaintiff had a tumor present and growing at the April 6, 1992 visit, the April 28, 1992 visit, and the August 13,1993 visit and the September 8,1993 visit. The court finds that at each of these visits, the physicians at the defendant facilities could have diagnosed plaintiffs cancer if they had performed adequate testing.

7. If plaintiffs cancer had been discovered when it first began manifesting symptoms at Stage I, plaintiff would not have had to undergo chemotherapy or radiation.

8. Because the diagnosis was delayed until the cancer had progressed to Stage III, plaintiff had to undergo both chemotherapy and radiation in addition to surgery.

9. Testimony at trial indicated that the chemotherapy and radiation treatments caused plaintiff to lose all of her hair, to become nauseated and to vomit routinely, to *360 be unable to cook or care for her family, to lose control of her bowel movements, to become unable to work, and to become dependent upon her relatives for her care.

. 10. If the cancer had been discovered when it first began manifesting symptoms at Stage I, plaintiffs chances of survival for five years would have been approximately 95 to 98 percent.

11. Because the diagnosis was delayed, plaintiffs chances for survival for five years are not more than 20 to 30 percent. Plaintiff has a reduced chance of survival because of the location of the tumor, the fact that four lymph nodes are involved, and because she is young and female. The court accepts Dr. Hellerstein’s appraisal that plaintiffs actual chances of five year survival are poor — “in the range of 20 percent.”

12. Evidence at trial established that plaintiff suffers emotional distress from her anticipated death, from her concerns of the effect on her elementary-school-aged daughter and her two other children, as well as from her anticipation of the extended treatment she may be forced to undergo in case of recurrence.

13. Dr. John Carter, plaintiffs surgeon, testified that most tumors recur in the first two years following surgery. Plaintiffs surgery took place on June 27,1994.

14. Plaintiffs cancer is presently undetectable.

15. If plaintiff survives five years from removal of the cancer, she returns to the general population in regard to prognosis and chance of survival.

16. If cancer recurs in the plaintiff, it can be treated. Any future medical expenses incurred by plaintiff in the event of recurrence will be paid by the government or plaintiffs private insurance company.

Conclusions of Law

1. The court has subject matter jurisdiction over this action pursuant to the Federal Tort Claims Act, 28 U.S.C. § 1346(b). Personal jurisdiction and venue are proper.

2. Under the Federal Tort Claims Act, the United States is liable in the same manner and to the same extent as a private individual in underlying circumstances. 28 U.S.C. § 2674. Under the Federal Tort Claims Act, the court is to apply the substantive law of the place where the act or omission occurred. Thus the substantive tort law of the state of Oklahoma applies in this action.

3. Under Oklahoma law, the three elements essential to a prima facie case of negligence are: (1) a duty owed by the defendant to protect the plaintiff from injury, (2) a failure to properly exercise or perform that duty, and (3) the plaintiffs injuries are proximately cause by the defendant’s failure to exercise his duty of care. McKellips v. Saint Francis Hospital, Inc., 741 P.2d 467, 470 (Okla.1987).

4. In McKellips, the Oklahoma Supreme Court adopted the loss of chance doctrine, specifically the approach taken in the Restatement (Second) of Torts, § 323. As applied in the arena of medical malpractice, § 323 relaxes the burden of proof which a plaintiff must provide with regard to causation. McKellips, 741 P.2d at 474.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Phillips v. Hillcrest Medical Center
244 F.3d 790 (Tenth Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
953 F. Supp. 358, 1996 U.S. Dist. LEXIS 21097, 1996 WL 780964, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bointy-tsotigh-v-united-states-okwd-1996.